Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
John Markels Insider Profile
4 Followers
John Markels, Director at Sangamo Biosciences, holds 3.13K shares in Arcturus Therapeutics (Ticker: ARCT), holds 71.38K shares in Sangamo Biosciences (Ticker: SGMO).
John Markels has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Markels holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by John Markels
John Markels's Trading History
Sangamo Biosciences
Jun 06, 2024
Director
Uninformative Buy
―
$134.20K
Arcturus Therapeutics
Jun 18, 2024
Director
Uninformative Buy
97.06K
$56.36K
List of latest transactions for each holding click on a transaction to see John Markels's performance on stock
You May Also Like
John Markels insider profile FAQ
What is the percentage of profitable transactions made by John Markels?
The percentage of profitable transactions made by John Markels is ―.
What is the average return per transaction made by John Markels?
The average return per transaction made by John Markels is ―.
What stocks does John Markels hold?
John Markels holds: SGMO, ARCT stocks.
What was John Markels’s latest transaction?
John Markels latest transaction was an Uninformative Buy of $97.06K.
What was John Markels's most profitable transaction?
John Markels’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is John Markels's role in Sangamo Biosciences?
John Markels's role in Sangamo Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.